We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

1 hedge funds and large institutions have $159K invested in Array Biopharma Inc in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 316 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 318 → 1 (-317)

100% less funds holding in top 10

Funds holding in top 10: 28 → 0 (-28)

100% less capital invested

Capital invested by funds: $10.5B → $159K (-$10.5B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 316

Holders
1
Holders Change
-317
Holders Change %
-99.69%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-28
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
316
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$943M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$890M
3
BlackRock
BlackRock
New York
-$824M
4
RG
Redmile Group
California
-$405M
5
FCM
Farallon Capital Management
California
-$394M
Name Holding Trade Value Shares
Change 		Change in
Stake
Nisa Investment Advisors
151
Nisa Investment Advisors
Missouri
– -$5.5M -118,800 Closed
GI
152
GAMCO Investors
Connecticut
– -$5.45M -117,708 Closed
State Board of Administration of Florida Retirement System
153
State Board of Administration of Florida Retirement System
Florida
– -$5.42M -117,014 Closed
GC
154
Guggenheim Capital
Illinois
– -$5.34M -115,289 Closed
AC
155
Athos Capital
Hong Kong
– -$5.21M -112,427 Closed
PI
156
Putnam Investments
Massachusetts
– -$5.14M -110,987 Closed
Voloridge Investment Management
157
Voloridge Investment Management
Florida
– -$5.09M -109,961 Closed
HA
158
Havens Advisors
New York
– -$5.07M -109,500 Closed
Capstone Investment Advisors
159
Capstone Investment Advisors
New York
– -$5.05M -109,059 Closed
Fisher Asset Management
160
Fisher Asset Management
Washington
– -$4.9M -105,726 Closed
NSIM
161
North Star Investment Management
Illinois
– -$4.63M -100,000 Closed
MIM
162
MetLife Investment Management
New Jersey
– -$4.57M -98,675 Closed
KCM
163
Kingdon Capital Management
New York
– -$4.46M -96,380 Closed
QI
164
QS Investors
New York
– -$4.38M -94,600 Closed
Los Angeles Capital Management
165
Los Angeles Capital Management
California
– -$4.32M -93,250 Closed
EAM
166
Exane Asset Management
France
– -$4.17M -90,000 Closed
BA
167
Boston Advisors
Massachusetts
– -$4.09M -88,336 Closed
ProShare Advisors
168
ProShare Advisors
Maryland
– -$4.04M -87,108 Closed
EU
169
Emory University
Georgia
– -$4.01M -86,567 Closed
NMC
170
Nine Masts Capital
Hong Kong
– -$3.98M -85,900 Closed
OGC
171
One68 Global Capital
New York
– -$3.94M -85,000 Closed
PAMP
172
Polar Asset Management Partners
Ontario, Canada
– -$3.94M -85,000 Closed
SMC
173
S. Muoio & Co
New York
– -$3.94M -85,000 Closed
KC
174
Kellner Capital
New York
– -$3.84M -82,900 Closed
HCM
175
Hollencrest Capital Management
California
– -$3.82M -82,500 Closed
5 6
7
8 9

ARRY Hedge Fund Activity: Q3 2019 in Review

1 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q3 2019, worth a combined $159K — down 100% from $10.5B a quarter earlier.

Sellers outnumbered buyers: 316 funds closed out of ARRY and 0 opened new positions — a net loss of 316 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $943M sold.

  • 1 institutional investor held Array Biopharma Inc (ARRY) as of Q3 2019, down from 318 in Q2 2019.
  • Funds reported $159K of Array Biopharma Inc stock for Q3 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Array Biopharma Inc positions in Q3 2019 and 316 closed out, a net change of -316 holders.
  • The largest Array Biopharma Inc seller in Q3 2019 was Vanguard Group, an estimated $943M sold.

Based on aggregated 13F filings for Q3 2019.